According to IMARC Group’s latest report, titled “Hemostats Market Analysis: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global hemostats market exhibited moderate growth during 2015-2020. Looking forward, the is expected the market to grow at a CAGR of 6.2% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Hemostats are the medical devices that compress blood vessels and reduce the flow of blood or other fluids. They are majorly used during surgical procedures to control bleeding in patients. Hemostatic agents enable faster wound healing, reduce operative time, enhance patient’s recovery, and help in treating anticoagulated patients. Various surgical hemostatic agents are available based on different compositions, immunogenicity, and the mechanism of action, application and adherence.
Request Free Sample Report: https://www.imarcgroup.com/hemostats-market/requestsample
Market Trends
The growing prevalence of chronic blood-related disorders, cesarean deliveries, fatal injuries, organ surgeries, etc., is primarily driving the demand for hemostats to reduce blood loss. Moreover, several technological advancements have led to the development of absorbable adjunctive hemostats that help in controlling disruptive bleeding more efficiently than the conventional devices. Additionally, the growing utilization of nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding is also augmenting the market growth. Several manufacturers have introduced advanced laparoscopic hemostats to enhance surgical operations quality and facilitate less invasive procedures, which are further expected to drive the global market.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/hemostats-market
List of Key Companies Covered in this Market Report:
Arch Therapeutics Inc.Baxter International Inc.Braun Melsungen AktiengesellR. Bard Inc.GELITA MEDICAL GmbHIntegra LifeSciences CorporationJohnson & JohnsonPfizer Inc.Stryker CorporationTeleflex IncorporatedZ-Medica LLC.The report has segmented the market on the basis of product, application, formulation and geography.
Breakup by Product:
Thrombin BasedCombination BasedOxidized Regenerated Cellulose BasedGelatin BasedCollagen BasedBreakup by Application:
Orthopedic SurgeryGeneral SurgeryNeurological SurgeryCardiovascular SurgeryReconstructive SurgeryGynecological SurgeryOthersBreakup by Formulation:
Matrix and Gel HemostatsSheet and Pad HemostatsSponge HemostatsPowder HemostatsBreakup by Geography:
North America (U.S. & Canada)Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)Latin America (Brazil, Mexico)Middle East & AfricaKey highlights of the report:
Market Performance (2015-2020)Market Outlook (2021- 2026)Porter’s Five Forces AnalysisMarket Drivers and Success FactorsSWOT AnalysisValue ChainComprehensive Mapping of the Competitive LandscapeIf you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Sign in to leave a comment.